Researchers at University College London (UCL) have developed an innovative artificial intelligence (AI) tool called MindGlide, designed to transform the way multiple sclerosis (MS) treatments are assessed.
Open Access Government looks into the National Institute of General Medical Sciences (NIGMS)’s Biochemistry and Bio-related Chemistry Branch, and its current research areas and priorities.
Those newly diagnosed with Type 2 diabetes and heart failure are at the greatest 5-year risk of death, according to scientists at The American Heart Association.
In the last six months GreenLight Medicines has successfully out-licenced leads from its research, branching out internationally and attracting major investors.
Neil Osheroff from the Vanderbilt University School of Medicine is working to overcome drug resistance and revitalise the use of established targets for antibacterial agents, as we discover here.
Here, Megan Warrender looks into the strides being made by the NIDCR to support dental research and innovation, and, in particular, how current initiatives feed into long term plans for dental, oral and craniofacial health and disease in the U.S.
